Facebook
Linkedin
Twitter
Home
News
COP Climate Change
COVID-19
Government
Health & Social Care
Coronavirus (COVID-19)
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
Environment
Circular Economy
Sustainable Development
Agriculture
Energy
Research & Innovation
Transport
Education
Finance
Workplace
Technology
Digital Transformation
Publications
Academic Articles
Special Reports
Government
Health & Social Care
Environment
Agriculture
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
Stakeholders
eBooks
Asia Analysis
North America Analysis
Subscribe
Search
Open Access Government
Open Access Government
Contact Us
About Us
Editors
Our Audience
Marketing Information Pack
Prestige Contributors
Testimonials
Open Access Government
Open Access Government
Linkedin
Twitter
Facebook
Instagram
Home
News
Publications
Academic Articles
Special Reports
Stakeholders
eBooks
Subscribe
Agriculture
Education
Energy
Environment
COP Climate Change
Circular Economy
Sustainable Development
Finance
Government
Health
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
COVID-19
Research
Technology
Digital Transformation
Transport
Workplace
North America
Asia
Search
Home
Alexander Gebauer – Secarna Pharmaceuticals GmbH & Co. KG
Alexander Gebauer
Chief Executive Officer
Secarna Pharmaceuticals GmbH & Co. KG
Contributor's Details
Phone:
+49 (0) 6421/9830050
Email:
info@secarna.com
Website:
Visit Website
LinkedIn:
Connect on LinkedIn
Contributor's Posts
Unraveling the potential of antisense therapies to target neuropilin 1 in the fight against cancer
Antisense therapies: A new approach to tackling challenging targets in areas of high unmet medical need
Secarna: Next generation antisense therapeutics